Category: Prostate Cancer Detection

Prostate cancer has a reputation as an older man's diagnosis, yet a growing number of men in their 20s, 30s, and 40s are hearing it too. Inherited gene mutations, missed early symptoms, and lifestyle factors all feed the trend, and younger patients often face later-stage disease. Early PSA testing paired with MRI offers a powerful way to catch trouble sooner. keep reading

As many as 75% of PSA tests come back falsely positive, and for years that single number sent men straight to a needle biopsy with all its risks. Today, noninvasive biomarker tests in blood and urine, paired with mpMRI, are reshaping who truly needs the procedure and who can safely be spared the discomfort and the worry. keep reading

A prostate MRI can detect cancer without contrast but how confident can a doctor be? DCE-MRI adds a third layer of information by capturing tumor blood flow patterns that plain MRI can't show. Gadolinium makes this possible, and modern formulations have an impressive safety record: over 170 million doses studied. keep reading

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading

Prostate cancer once looked simple. It isn't. Science now knows there are at least 15 distinct cell lines, a single tumor can harbor multiple, and each patient's cancer behaves differently. Genomic biomarker tests are changing how doctors navigate that complexity, defining risk more precisely and helping tailor treatment to the individual. keep reading

Whole Body MRI and PSMA-PET scans are leading tools for detecting prostate cancer that has spread beyond the gland. Recent studies suggest Whole Body MRI may hold a slight edge in accuracy, especially for predicting risk and tracking treatment, while both remain vital for planning care. keep reading

Recent studies reveal the digital rectal exam may not improve early prostate cancer detection compared to PSA testing. As experts question its usefulness, advanced tools like multiparametric MRI are shaping modern screening guidelines. keep reading

A European study of nearly 600 men found that negative prostate MRI results accurately predicted no cancer in 96% of cases. Over three years, most men safely avoided biopsy while being monitored, suggesting pre-biopsy MRI can reduce unnecessary procedures without added risk. keep reading

Each year, hundreds of thousands of men undergo prostate biopsies triggered by PSA results—many of them unnecessary. New research shows that combining PSA testing with MRI can more accurately identify significant cancers while sparing men from needless biopsies and the harms of overtreatment. keep reading

A British clinical trial and new Italian study highlight how pairing MRI with PSA density could change prostate cancer detection. By refining who needs biopsy, this method offers earlier diagnosis of significant cancers while avoiding unnecessary procedures. keep reading